ED50 of Esketamine for Laser Treatment in Children - Trial NCT06294639
Access comprehensive clinical trial information for NCT06294639 through Pure Global AI's free database. This phase not specified trial is sponsored by Air Force Military Medical University, China and is currently Not yet recruiting. The study focuses on Anesthesia. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Air Force Military Medical University, China
Timeline & Enrollment
N/A
Mar 27, 2024
Apr 27, 2025
Primary Outcome
half effective dose of inhibition of body movement
Summary
There is limited research on the combined use of esketamine and alfentanil for anesthesia
 during facial laser treatment in pediatric patients, and the effective dosage of esketamine
 for inhibiting body movement remains unclear. We explore the effective dose of esketamine
 combined with alfentanil for the inhibition of body movement during facial laser treatment in
 pediatric patients.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06294639
Non-Device Trial